6th Circ. Backs Drugmakers' Early Win In Diabetes Drug MDL
The Sixth Circuit on Tuesday affirmed an early victory for AstraZeneca Pharmaceuticals LP, Bristol Myers Squibb Co. and McKesson Corp. in multidistrict litigation alleging the diabetes drugs they manufacture, Onglyza and...To view the full article, register now.
Already a subscriber? Click here to view full article